Cytokine Signature in Convalescent SARS-CoV-2 Patients with Inflammatory Bowel Disease Receiving Vedolizumab

Investigators found a cytokine signature in patients receiving vedolizumab who were seropositive compared with seronegative for SARS-CoV-2 antibodies that may be linked to repeated SARS-CoV-2 infections.